Volltext-Downloads (blau) und Frontdoor-Views (grau)

Cost-effectiveness Study of Antidiabetic Drugs in Type 2 Diabetes Mellitus Patients From Mumbai, India

  • Diabetes is fast gaining the status of a potential epidemic in India, with >62 million individuals currently diagnosed with the disease.1 India currently faces an uncertain future in relation to the potential burden that diabetes may impose on the country. An estimated US$ 2.2 billion would be needed to sufficiently treat all cases of type 2 diabetes mellitus (T2DM) in India.2 Many interventions can reduce the burden of this disease. However, health care resources are limited; thus, interventions for diabetes treatment should be prioritized.

Download full text files

Export metadata

Additional Services

Search Google Scholar


Author:Dnyanesh LimayeORCiDGND, K. Todi, J. Shroff, A. Ramaswamy, P. Kulkarni, Vaidehi Limaye, Gerhard FortwengelORCiDGND
Parent Title (English):Current Therapeutic Research
Document Type:Article
Release Date:2016/07/14
Tag:India; antidiabetic; cost-effectiveness; diabetes mellitus
First Page:S2
Last Page:S3
Link to catalogue:1684942969
Institutes:Fakult├Ąt III - Medien, Information und Design
DDC classes:610 Medizin, Gesundheit
Licence (German):License LogoCreative Commons - CC BY-NC-ND - Namensnennung - Nicht kommerziell - Keine Bearbeitungen 4.0 International